rs78904893

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_057176.3(BSND):​c.177+11G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0336 in 1,600,054 control chromosomes in the GnomAD database, including 2,557 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.068 ( 612 hom., cov: 32)
Exomes 𝑓: 0.030 ( 1945 hom. )

Consequence

BSND
NM_057176.3 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: -0.532

Publications

5 publications found
Variant links:
Genes affected
BSND (HGNC:16512): (barttin CLCNK type accessory subunit beta) This gene encodes an essential beta subunit for CLC chloride channels. These heteromeric channels localize to basolateral membranes of renal tubules and of potassium-secreting epithelia of the inner ear. Mutations in this gene have been associated with Bartter syndrome with sensorineural deafness. [provided by RefSeq, Jul 2008]
BSND Gene-Disease associations (from GenCC):
  • Bartter disease type 4A
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, G2P, PanelApp Australia
  • Bartter syndrome type 4
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • hearing loss, autosomal recessive
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.62).
BP6
Variant 1-54999374-G-A is Benign according to our data. Variant chr1-54999374-G-A is described in ClinVar as Benign. ClinVar VariationId is 46546.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.145 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
BSNDNM_057176.3 linkc.177+11G>A intron_variant Intron 1 of 3 ENST00000651561.1 NP_476517.1 Q8WZ55Q5VU50

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
BSNDENST00000651561.1 linkc.177+11G>A intron_variant Intron 1 of 3 NM_057176.3 ENSP00000498282.1 Q8WZ55

Frequencies

GnomAD3 genomes
AF:
0.0680
AC:
10337
AN:
152120
Hom.:
609
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.149
Gnomad AMI
AF:
0.0208
Gnomad AMR
AF:
0.101
Gnomad ASJ
AF:
0.0490
Gnomad EAS
AF:
0.125
Gnomad SAS
AF:
0.0739
Gnomad FIN
AF:
0.0214
Gnomad MID
AF:
0.123
Gnomad NFE
AF:
0.0152
Gnomad OTH
AF:
0.0742
GnomAD2 exomes
AF:
0.0643
AC:
15698
AN:
244242
AF XY:
0.0576
show subpopulations
Gnomad AFR exome
AF:
0.151
Gnomad AMR exome
AF:
0.168
Gnomad ASJ exome
AF:
0.0494
Gnomad EAS exome
AF:
0.125
Gnomad FIN exome
AF:
0.0236
Gnomad NFE exome
AF:
0.0168
Gnomad OTH exome
AF:
0.0578
GnomAD4 exome
AF:
0.0300
AC:
43374
AN:
1447818
Hom.:
1945
Cov.:
32
AF XY:
0.0303
AC XY:
21762
AN XY:
717690
show subpopulations
African (AFR)
AF:
0.154
AC:
5125
AN:
33262
American (AMR)
AF:
0.159
AC:
7075
AN:
44384
Ashkenazi Jewish (ASJ)
AF:
0.0499
AC:
1282
AN:
25682
East Asian (EAS)
AF:
0.144
AC:
5671
AN:
39388
South Asian (SAS)
AF:
0.0686
AC:
5857
AN:
85406
European-Finnish (FIN)
AF:
0.0241
AC:
1254
AN:
52048
Middle Eastern (MID)
AF:
0.0850
AC:
467
AN:
5494
European-Non Finnish (NFE)
AF:
0.0127
AC:
13958
AN:
1102480
Other (OTH)
AF:
0.0450
AC:
2685
AN:
59674
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.489
Heterozygous variant carriers
0
2123
4246
6368
8491
10614
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
786
1572
2358
3144
3930
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0681
AC:
10361
AN:
152236
Hom.:
612
Cov.:
32
AF XY:
0.0685
AC XY:
5099
AN XY:
74438
show subpopulations
African (AFR)
AF:
0.148
AC:
6163
AN:
41534
American (AMR)
AF:
0.101
AC:
1548
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.0490
AC:
170
AN:
3472
East Asian (EAS)
AF:
0.126
AC:
648
AN:
5148
South Asian (SAS)
AF:
0.0740
AC:
357
AN:
4826
European-Finnish (FIN)
AF:
0.0214
AC:
227
AN:
10626
Middle Eastern (MID)
AF:
0.139
AC:
41
AN:
294
European-Non Finnish (NFE)
AF:
0.0152
AC:
1032
AN:
68014
Other (OTH)
AF:
0.0739
AC:
156
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
448
896
1345
1793
2241
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
110
220
330
440
550
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0358
Hom.:
100
Bravo
AF:
0.0806
Asia WGS
AF:
0.102
AC:
354
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 30, 2012
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

177+11G>A in Intron 01 of BSND: This variant is not expected to have clinical si gnificance because it is not located within the conserved splice consensus seque nce and has been identified in 14.5% (543/3738) of African American chromosomes from a broad population by the NHLBI Exome Sequencing Project (http://evs.gs.was hington.edu/EVS; dbSNP rs78904893). -

Apr 29, 2016
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:3
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jul 05, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Bartter disease type 4A Benign:2
Jul 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.62
CADD
Benign
9.9
DANN
Benign
0.82
PhyloP100
-0.53
PromoterAI
0.029
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs78904893; hg19: chr1-55465047; COSMIC: COSV64870904; API